Toshifumi Suzuki Pioneer of Japans Convenience Store Revolution Dies at 93 UK Spy Chief Warns West Faces Moment of Consequence Amid Threats From Russia and China Bessent Forecasts Substantial Disinflation Ahead as Warsh Assumes Fed Leadership Bajaj Auto Shares Rise Ahead of Dividend Record Date Company Sets May 29 Payout Eligibility Geopolitical Tensions Escalate After Putin Vows Retaliation for Ukraine Strike on Drone Unit Options Trading Without the BlackScholes Model The Case for ChartBased Strategies WES Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency GEGGL Q1 2026 Earnings Significant EPS Miss with No Revenue Reported ERIE Q1 2026 Earnings Earnings Miss Estimates Amidst Rising Costs Sonoma Pharmaceuticals Inc SNOA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Thin Revenue Disclosures Purple Innovation Inc PRPL Q1 2026 Earnings EPS Meets Estimates with Narrow Beat Shares Edge Lower GBLI Q1 2026 Earnings Significant EPS Miss Underscores Underwriting Challenges Pioneer Bancorp Inc PBFS Shows Mild Uptick Amid Consolidation Above Key Support Cronos Group CRON Surges 44 as Cannabis Sector Momentum Gathers Pace Shenandoah Telecommunications SHEN Slips 1 as Stock Hovers Near Key Support Stellantis STLA Rebounds Sharply Key Levels to Watch After Surge DMII Holds Steady at 1007 as SPAC Shares Track Trust Value ICRA Flags Sharp Decline in IBC Recovery Rates to 22 in H2 FY26 Compugen Ltd Q1 2026 Earnings Narrowing Losses but Misses Estimates FACT II Acquisition Corp Unit FACTU Holds Steady at 1145 Amidst SPAC Market Consolidation JLL Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty EQX Q1 2026 Earnings Modest EPS Miss Amid Positive Market Reaction AFB Q3 2024 Earnings Solid Net Investment Income Amid Stable Municipal Bond Market REKR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Drops OPCH Q1 2026 Earnings EPS Beat Amid Caution Stock Slips 191 Hyperfine Inc HYPR Q1 2026 Earnings Narrower Loss Beats Estimates But Stock Slips Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline